Comparison Chart Armata Pharmaceuticals, Inc.

Stocks

ARMP

US04216R1023

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 19:31:57 26/10/2026 +04			5-day change	1st Jan Change
3.585 ^USD	-1.51%		+16.94%	-42.83%

10-07	Armata Pharmaceuticals, Inc. Strengthens Intellectual Property Portfolio with Two Recent Patent Issuances Covering Ap-Sa02 and Ap-Pa02	CI
09-23	Armata Pharmaceuticals Receives Additional Non-Dilutive Funding To Support AP-SA02 Phase 3 Development	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	ARMATA PHARMACEUTICALS, INC.	Bio Therapeutic Drugs	-1.37%	+16.94%	-42.83%	-31.88%	+19.67%	135M